ModivCare (MODV)
(Delayed Data from NSDQ)
$23.84 USD
+0.28 (1.19%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $23.87 +0.03 (0.13%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth F Momentum D VGM
Income Statements
Fiscal Year end for ModivCare Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 2,751 | 2,504 | 1,997 | 1,369 | 1,510 |
Cost Of Goods | 2,304 | 2,032 | 1,584 | 1,079 | 1,401 |
Gross Profit | 447 | 472 | 413 | 290 | 109 |
Selling & Adminstrative & Depr. & Amort Expenses | 587 | 415 | 323 | 167 | 84 |
Income After Depreciation & Amortization | -140 | 57 | 90 | 123 | 25 |
Non-Operating Income | 0 | 0 | 0 | 9 | -29 |
Interest Expense | 69 | 62 | 49 | 18 | 1 |
Pretax Income | -209 | -5 | 41 | 114 | -6 |
Income Taxes | -4 | -3 | 9 | 25 | -1 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | -30 | -38 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -204 | -32 | -6 | 90 | -5 |
Extras & Discontinued Operations | 0 | 0 | 0 | -1 | 6 |
Net Income (GAAP) | -204 | -32 | -7 | 89 | 1 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 153 | 163 | 149 | 150 | 42 |
Depreciation & Amortization (Cash Flow) | 293 | 106 | 60 | 27 | 17 |
Income After Depreciation & Amortization | -140 | 57 | 90 | 123 | 25 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 14.17 | 14.06 | 14.05 | 13.68 | 12.96 |
Diluted EPS Before Non-Recurring Items | 5.25 | 7.01 | 7.89 | 6.95 | 1.65 |
Diluted Net EPS (GAAP) | -14.43 | -2.26 | -0.47 | 2.37 | -0.26 |
Fiscal Year end for ModivCare Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 698.18 | 687.48 | 701.74 | 663.77 |
Cost Of Goods | NA | 585.48 | 579.21 | 589.26 | 550.27 |
Gross Profit | NA | 112.70 | 108.26 | 112.49 | 113.50 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 102.06 | 96.22 | 288.25 | 105.40 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 10.64 | 12.04 | -175.76 | 8.10 |
Non-Operating Income | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | NA | 18.35 | 17.84 | 16.97 | 15.96 |
Pretax Income | NA | -2.68 | -5.80 | -192.73 | -7.86 |
Income Taxes | NA | 0.04 | -1.66 | -0.83 | -1.87 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | -2.53 | -0.16 | 0.96 | 2.03 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -5.25 | -4.30 | -190.94 | -3.96 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -5.25 | -4.30 | -190.94 | -3.96 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 14.19 | 14.18 | 14.17 | 14.16 |
Diluted EPS Before Non-Recurring Items | NA | 1.18 | 1.35 | 1.41 | 1.37 |
Diluted Net EPS (GAAP) | NA | -0.38 | -0.30 | -13.47 | -0.28 |